{
  "url": "https://www.law.cornell.edu/regulations/new-york/11-NYCRR-361.4",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 11 ยง 361.4 - Pooling of the cost of treating specified medical conditions prior to January 1, 1999",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 11 ยง 361.4 - Pooling of the cost of treating specified medical conditions prior to January 1, 1999\n\nState Regulations\n(a) In each pool area, a specified medical condition pooling fund is established. Each pool operates independently; that is, all calculations and payments described below are made for each pool independently of any other pool. (b) Each carrier shall pay to the pooling fund each quarter, beginning with the second quarter of 1993, and ending December 31, 1998, an amount determined as the product of paragraphs (1), (2), and (3) of this subdivision: (1)\n\nAn amount determined by the superintendent each year by September 1st, with respect to payments required during the subsequent calendar year. For 1993, this amount will be $5. (2)\n\nThe number of family units with coverage of a single individual under a pooled insurance contract or policy, other than a Medicare supplement insurance policy, as of the beginning of the quarter, plus twice the number of family units with dependents coverage by the carrier under a pooled insurance contract or policy, other than a Medicare supplement insurance policy, as of the beginning of the quarter. (3)\nA coverage factor, as follows: Type of Contract\n\nCoverage Factor\n\nBasic Hospital or Basic Hospital/Surgical\n0.75\n\nWraparound or Supplemental Major Medical\n0.25\n\nBasic and Supplemental Major Medical, Comprehensive Major Medical, HMO\n1.0\n(c) Each carrier may collect from the pooling fund in lump sum an amount listed in Table 1, subdivision (e) of this section, for claims incurred prior to January 1, 1997 and in lump sum an amount listed in Table 3, subdivision (e) of this section for claims incurred between January 1, 1997 and December 31, 1997 (but in no event more than the carrier is required to pay for the care of the listed medical condition), by submitting a claim in the calendar year following the calendar year in which the claim was incurred except that the deadline for filing 1997 claims is extended from December 31, 1998 to July 31, 2000, upon certification to the superintendent by the carrier that: (1)\nan individual has been diagnosed as having one of the medical conditions listed in Table 1 or Table 3, subdivision (e) of this section as applicable, and the course of medical care identified in Table 1 or Table 3 has been recommended and completed; (2)\nthe identified individual is covered by the carrier under a pooled insurance contract or policy, other than a Medicare supplement insurance policy, for the identified medical care; and\n(3)\nno other carrier or other third-party payor has primary responsibility for the cost of that medical care. In the event that the individual changes carriers or is covered by more than one carrier under pooled insurance contracts or policies, other than a Medicare supplement insurance policy, during the course of the identified medical care, payment from the pooling fund of the amount listed in Table 1 or Table 3, subdivision (e) of this section, shall be pro-rated among the carriers based upon each carrier's proportionate share of the cost of the identified medical care. Insurers and HMOs may not base decisions as to whether a course of medical care is covered by an insurance or HMO policy or contract on the presence of that course of medical care in Table 1 or Table 3, subdivision (e) of this section, or the absence of that course of medical care from Table 1 or Table 3. Distributions from the pooling fund of the amounts listed in Table 1 or Table 3, subdivision (e) of this section, shall be made based upon the month in which the claim attributable to expenses was incurred by the carrier. Older claims, based on the date the medical service was provided, will be given priority for payment over more recent claims. (d) Each carrier may collect from the pooling fund each month an amount listed in Table 2, subdivision (e) of this section, for claims incurred prior to January 1, 1997 and each month an amount listed in Table 4, subdivision (e) of this section for claims incurred between January 1, 1997 and December 31, 1997, but in no event more than the carrier is required to pay for the care of the listed medical condition, by submitting a claim in the calendar year following the calendar year in which the claim was incurred except that the deadline for filing 1997 claims is extended from December 31, 1998 to July 31, 2000, upon certification to the superintendent by the carrier that: (1)\nan individual has been diagnosed as having one of the medical conditions listed in Table 2 or Table 4, subdivision (e) of this section as applicable; (2)\nthe identified individual is covered by the carrier under a pooled insurance contract or policy, other than a Medicare supplement insurance policy, with respect to medical care for the identified medical condition as of the end of each month for which reimbursement is sought; and\n(3)\nno other carrier or other third-party payor has primary responsibility for the cost of that medical care. In the event that the individual is covered by more than one carrier under a pooled insurance contract or policy, other than a Medicare supplement insurance policy, payments from the pooling fund of the amount listed in Table 2 or Table 4, subdivision (e) of this section, shall be pro-rated among the carriers based upon each carrier's proportionate share of the cost of medical care for the identified medical condition. Distributions from the pooling fund of the amounts listed in Table 2 or Table 4, subdivision (e) of this section, shall be made based upon the month in which the claim attributable to expenses was incurred by the carrier. Older claims, based on the date the medical service was provided, will be given priority for payment over more recent claims. (e) Tables. Table 1\n\nMedical Condition\n\nCourse of Medical Care\n\nPool Payment\n\nIrreversible, progressive liver disease\n\nLiver transplantation\n$ 80,000\n\nIrreversible, progressive heart disease\n\nHeart transplantation\n76,000\n\nIrreversible, progressive pancreas disease\n\nPancreas transplantation\n56,000\n\nIrreversible, progressive lung disease\n\nPulmonary transplantation\n136,000\n\nSevere aplastic anemia\n\nBone marrow transplantation\n120,000\n\nAcute leukemia\n\nBone marrow transplantation\n120,000\n\nChronic myelogenous leukemia (CML) in controlled (not blastic) phase\n\nBone marrow transplantation\n120,000\n\nNeuroblastoma, Stage III or Stage IV in complete remission\n\nBone marrow transplantation\n120,000\n\nMyelodysplastic syndrome\n\nBone marrow transplantation\n120,000\n\nHodgkins disease\n\nBone marrow transplantation\n120,000\n\nNon-Hodgkins lymphoma\n\nBone marrow transplantation\n120,000\n\nSevere combined immune deficiencies (SCID)\n\nBone marrow transplantation\n120,000\n\nWiskott-Aldrich Syndrome\n\nBone marrow transplantation\n120,000\n\nOther condition, approved by the Superintendent in clinical situations where bone marrow transplantation has proven to be effective\n\nBone marrow transplantation\n120,000\n\nNeonate with birth weight of less than 1500 grams\nICU care for more than 30 days\n96,000\n\nTable 2\n\nMedical Condition\n\nMonthly Payment\nHIV disease where the CD4 count is below 50 on two consecutive tests\n$ 2,000\nALS leading to ventilator dependency for more than 30 days\n13,000\n\nSevere trauma leading to ventilator dependency for more than 30 days\n13,000\n\nSevere muscular dystrophy leading to ventilator dependency for more than 30 days\n13,000\n\nTable 3\n\nMedical Condition or Criteria\n\nCourse of Medical Care or Primary Diagnoses\n\nMaximum Pool Payment\nAIDS\nICD-9 code 042, 043, 044, 136.3, 117.5, 112.81 through 112.85, 176; or use of any of attached Drugs in Table 5 for treatment of AIDS\n$ 10,000\n\nIrreversible, progressive liver disease\n\nLiver transplantation\n80,000\n\nIrreversible, progressive heart disease\n\nHeart transplantation\n76,000\n\nIrreversible, progressive pancreas disease\n\nPancreas transplantation\n56,000\n\nIrreversible, progressive lung disease\n\nPulmonary transplantation\n136,000\n\nIrreversible, progressive kidney disease\n\nKidney transplantation not covered by Medicare\n56,000\n\nMedical necessity\n\nBone marrow and stem cell procedures; CPT codes 38240 or 38241\n120,000\n\nMultiple Sclerosis\nICD9 Code 340 plus use of medicines J1825 or J1830\n7,500\n\nNeonatal distress\nICU care for more than 30 days\n96,000\n\nGaucher's disease\n\nUse of medicines J0205, J1785 or NDC codes 58468178101, 58468106001 or 58468198301\n75,000\n\nHemophilia with clotting factor VIII or IX\nICD9 code 286.0, 286.1, 286.2, 286.4, 286.7 plus use of medicines J7190, J7191, J7129, J7194, or J7196; or treatment with drugs listed in Table 6\n50,000\n\nTable 4\n\nMedical Condition\n\nMonthly Payment\nALS leading to ventilator dependency for more than 30 days\n$13,000\n\nSevere trauma leading to ventilator dependency for more than 30 days\n13,000\n\nSevere muscular dystrophy leading to ventilator dependency for more than 30 days\n13,000\n\nVentilator dependency with procedure code CPT 94657 of 30 units or more in given calendar year\n13,000\n\nTable 5\nHIV/AIDS\nFDB Label Name\nNDC Labeler Code\nNDC Product Code\n\nManufacturer/ Package Size\nCOMBIVIR TABLET\n00173\n0595\n00\nCOMBIVIR TABLET\n00173\n0595\n02\nCRIXIVAN 200 MG CAPSULE\n00006\n0571\n42\nCRIXIVAN 200 MG CAPSULE\n00006\n0571\n43\nCRIXIVAN 400 MG CAPSULE\n00006\n0573\n54\nCRIXIVAN 400 MG CAPSULE\n00006\n0573\n62\nEPIVIR 10MG/ML ORAL SOLN\n00173\n0471\n00\nEPIVIR 150MG TABLET\n00173\n0470\n01\nFORTOVASE 200MG SOFTGEL\n00004\n0246\n48\nHIVID 0.375MG TABLET\n00004\n0220\n01\nHIVID 0.75MG TABLET\n00004\n0221\n01\nINVIRASE 200MG CAPSULE\n00004\n0245\n15\nINVIRASE 200MG CAPSULE\n54569\n4242\n01\nNORVIR 100MG CAPSULE\n00074\n8492\n02\nNORVIR 100MG CAPSULE\n00074\n9492\n54\nNORVIR 100MG CAPSULE\n54569\n4335\n00\nNORVIR 100MG CAPSULE\n54888\n3782\n00\nNORVIR 80MG/ML SOLUTION\n00074\n1940\n63\nRESCRIPTOR 100MG TABLET\n00009\n3761\n03\nRETROVIR 100MG CAPSULE\n00081\n0108\n56\nRETROVIR 100MG CAPSULE\n00173\n0108\n55\nRETROVIR 100MG CAPSULE\n00173\n0108\n56\nRETROVIR 10MG/ML SYRUP\n00173\n0113\n18\nRETROVIR 300MG TABLET\n00173\n0501\n00\nVIDEX 100MG PACKET\n00087\n6614\n43\nVIDEX 100MG TABLET CHEWABLE\n00087\n6852\n01\nVIDEX 100MG TABLET CHEWABLE\n00087\n6627\n43\nVIDEX 150MG TABLET CHEWABLE\n00087\n6653\n01\nVIDEX 150MG TABLET CHEWABLE\n00087\n6626\n43\nVIDEX 157MG PACKET\n00087\n6616\n43\nVIDEX 250MG PACKET\n00087\n6616\n43\nVIDEX 25MG TABLET CHEWABLE\n00087\n6628\n43\nVIDEX 4GM PEDIATRIC SOLN\n00087\n6833\n41\nVIDEX 50MG TABLET CHEWABLE\n00087\n6651\n01\nVIDEX 50MG TABLET CHEWABLE\n00087\n6624\n43\nVIRACEPT 250MG TABLET\n63010\n0010\n27\nVIRACEPT POWDER\n63010\n0011\n90\nVIRAMUNE 200 MG TABLET\n00054\n4647\n21\nVIRAMUNE 200 MG TABLET\n00054\n4647\n25\nVIRAMUNE 200 MG TABLET\n00054\n8647\n25\nVIRAMUNE 200 MG TABLET\n54868\n3844\n00\nVIRAMUNE SUSP 50MG/5ML\n00054\n3905\n58\nZERIT 20MG CAPSULE\n00003\n1965\n01\nZERIT 30MG CAPSULE\n00003\n1968\n01\nZERIT 30MG CAPSULE\n54569\n4053\n00\nZERIT 40MG CAPSULE\n00003\n1967\n01\nSUSTIVA 50MG CAPSULE\n00056\n0470\n30\nSUSTIVA 100MG CAPSULE\n00056\n0473\n30\nSUSTIVA 200MG CAPSULE\n00056\n0474\n92\n\nTable 6\n\nFactor VIII and IX NDC Codes\nNDC\nDrug name\n\nManufacturer\n52769-0460-01\n\nAntIhemop HU INJ 306-1170\nAM RED CRO\n13143-0321-63\n\nFactor VIII inj 500-1200\nMEL BIOLOG\n00026-0664-30\nKOATE-HP 500IU\nBAYER BIOL\n00053-7605-02\nHUMATE-P 500IU\nCENTEON\n13143-0321-55\nMELATE 500IU\nMEL BIOLOG\n52789-0480-01\nANTIHEMOP HU ING 308-1170\nAM RED CRO\n00026-0664-50\nKOATE-HP INJ 1000IU\nBAYER BIOL\n00053-7605-04\nHUMATE-P HU ING 1000IU\nCENTEON\n00053-7656-04\nMONOCLA-P HU INJ 1000IU\nCENTEON\n13143-0321-56\nMELATE 1000IU\nMEL BIOLOG\n00026-0664-80\nKOATE HP 1500IU\nBAYER BIOL\n00053-7656-01\nMONOCLA-P HU 250AHFU\nCENTEON\n00063-7658-01\nMONOCLATE 600AHFU\nARMOUR\n55688-0106-02\nHYATE:C INJ 400-700U\nSPEYWOOD\n00026-0670-20\nKOGENATE 250 AHFU\nBAYER PHAR\n00053-8110-01\nBIOCLATE 250IU\nCENTEON\n00053-8120-01\nHELIXATE 260IU\nCENTEON\n00944-2938-01\nRECOMBINATE 220-400\nBAXHYLAND\n00026-0670-30\nKOGENATE 500AHFU\nBAYER BIOL\n00053-8110-02\nBIOCLATE 500IU\nCENTEON\n00053-8120-02\nHELIXATE 500IU\nCENTEON\n00944-2938-02\nRECOMBINATE 401-800\nBAXHYLAND\n00026-0670-30\nKOGENATE 500AHFU\nBAYER BIOL\n00053-8110-02\nBIOCLATE 600IU\nCENTEON\n00053-8120-02\nHELIXATE 500IU\nCENTEON\n00944-2938-02\nRECOMBINATE 401-800\nBAXHYLAND\n00028-0670-50\nKOGENATE 1000AHFU\nBAYER BIOL\n00053-8110-04\nBIOCLATE 1000IU\nCENTEON\n00944-2938-03\nRECOMBINATE 801-1240\nBAXHYLAND\n49889-3800-02\nALPHANINE SD 250-1600\nALPHA THER\n00053-7668-01\nMONONINE 250IU\nCENTEON\n00053-7668-02\nMONONINE 500IU\nCENTEON\n00053-7668-04\nMONONINE 1000IU\nCENTEON\n58394-0003-01\nBENEFIX 250IU\nGENETICSIN\n58394-0002-01\nBENEFIX 500IU\nGENETICSIN\n58394-0001-01\nBENEFIX 1000IU\nGENETICSIN\n00026-0626-20\nKONYNE 80 500IU\nBAYER BIOL\n00944-0581-01\nPROPLEX T FACT IX\nBAXHYLAND\n49669-3200-02\nPROFILNILE 500IU\nALPHA THER\n00026-0626-50\nKONYNE 80 1000IU\nBAYER BIOL\n49689-3200-03\nPROFILNILE 1000IU\nALPHA THER\n54129-0244-02\nBEBULIN VH 200-1200\nIMMUNO\n(f) The pooling of the cost of treating specified medical conditions for claims incurred in 1998 shall occur as follows: (1)\n\nSeparately for each carrier, add the dollar amounts shown in Table 3, subdivision (e) of this section for each individual specified medical condition claim incurred during 1998 and listed in Table 3 and six times the dollar amounts shown in Table 4, subdivision (e) of this section for each individual specified medical condition claim incurred during 1998 and listed in Table 4. No individual can be counted more than once. If an individual has multiple conditions, assign to such individual the condition with the largest dollar amount. This total shall be the carrier's own total maximum specified medical condition claims. (2)\n\nSeparately for each carrier, the total maximum specified medical condition claims from paragraph (1) of this subdivision shall be divided by that carrier's 1998 contributions to the specified medical condition pool (as required by subdivision [b] of this section) to obtain that carrier's specified medical condition index. (3)\n\nThe regional specified medical condition index for all carriers in a specific region shall be subparagraph (i) divided by subparagraph (ii) of this paragraph: (i) The sum for all carriers in the region of the total maximum specified medical condition claims as determined in paragraph (1) of this subdivision. (ii)\n\nThe sum for all carriers in the region of the 1998 contributions to the specified medical condition pool in that region. (4)\n\nThe carriers participating in the regional specified medical condition pool shall only be entitled to collect from the pool if the carrier's own specified medical condition index, determined by paragraph (2) of this subdivision, is greater than the regional specified medical condition index, determined by paragraph (3) of this subdivision, for that pool as of the end of 1998. Individual specified medical condition claims will no longer be reimbursed by the pool in 1998. (5)\nA carrier entitled to collect from the 1998 specified medical condition pooling fund as determined by paragraph (4) of this subdivision may collect the product of subparagraphs (i) and (ii) of this paragraph: (i) That carrier's percentage of the specified medical condition funds, determined by dividing clause (\na\n) by clause (\nb\n) of this subparagraph: (a) the amount by which the carrier's specified medical condition index is greater than the regional specified medical condition index weighted by the carrier's own 1998 specified medical condition contributions to the regional pool (determined by subtracting the regional specified medical condition index from the specified medical condition index for that carrier and then multiplying the result of the subtraction by the carrier's own 1998 specified medical condition contributions to the regional pool); (b) the sum of the amounts determined in clause (\na\n) of this subparagraph for all carriers in the regional pool who are entitled to collect from the 1998 specified medical condition pooling fund. (ii)\n\nThe sum of the 1998 specified medical condition funds available for distribution in that region plus the amount of funds for 1998 representing the 55 percent reduction in demographic payments in that region to pools that deal with individual health insurance policies and small group health insurance policies, other than Medicare supplement insurance policies. (6)\nA carrier shall only be entitled to collect from the 1998 specified medical condition pooling fund an amount calculated pursuant to the method established in paragraphs (4) and (5) of this subdivision upon certification to the superintendent by the carrier by no later than July 31, 2000, that with respect to the claims reported to the administrator and used in paragraph (1) of this subdivision that: (i) regarding the medical conditions listed in Table 3, subdivision (e) of this section: (a) an individual has been diagnosed as having one of the medical conditions or criteria listed in Table 3, subdivision (e) of this section, and the course of medical care identified in Table 3 has been recommended and completed; (b) the identified individual is covered by the carrier under a pooled insurance contract or policy, other than a Medicare supplement insurance policy, for the identified medical care; and\n(c) no other carrier or other third-party payor has primary responsibility for the cost of that medical care; (ii)\nregarding the medical conditions listed in Table 4, subdivision (e) of this section: (a) an individual has been diagnosed as having one of the medical conditions listed in Table 4, subdivision (e) of this section; (b) the identified individual is covered by the carrier under a pooled insurance contract or policy, other than a Medicare supplement insurance policy, with respect to medical care for the identified medical condition as of the end of each month for which reimbursement is sought; and\n(c) no other carrier or other third-party payor has primary responsibility for the cost of that medical care. (g) A carrier must report the number of claims that have been incurred for 1998 separately for each category listed in Table 3, subdivision (e) of this section and Table 4, subdivision (e) of this section in a manner prescribed by the superintendent. Notes\nN.Y. Comp. Codes\nR. & Regs. Tit. 11\nยง\n361.4\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. No prior version found.",
  "url_type": "regulation",
  "source_index": 16230
}